Expert Review of Molecular Diagnostics

Papers
(The median citation count of Expert Review of Molecular Diagnostics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Real-time RT-PCR in COVID-19 detection: issues affecting the results823
LAMP Diagnostics at the Point-of-Care: Emerging Trends and Perspectives for the Developer Community100
Cystatin C as a biomarker of chronic kidney disease: latest developments54
Saliva as a diagnostic tool for dental caries, periodontal disease and cancer: is there a need for more biomarkers?42
The diagnostic methods in the COVID-19 pandemic, today and in the future39
Spectroscopy as a tool for detection and monitoring of Coronavirus (COVID-19)38
The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis36
Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing antibodies34
Developing multiplex ddPCR assays for SARS-CoV-2 detection based on probe mix and amplitude based multiplexing31
Diagnosis for COVID-19: current status and future prospects29
A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)28
Advances in tests for colorectal cancer screening and diagnosis27
Noninvasive detection of COPD and Lung Cancer through breath analysis using MOS Sensor array based e-nose27
Role of N6-methyladenosine modification in pathogenesis of ischemic stroke25
The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery24
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome22
Emerging circulating MiRNAs and LncRNAs in upper gastrointestinal cancers22
Urine as a biological modality for colorectal cancer detection22
A review on current diagnostic techniques for COVID-1921
Critical insight into recombinase polymerase amplification technology21
Ultrasensitive circulating tumor DNA analysis enables precision medicine: experimental workflow considerations20
Enzymatic cross-linking of collagens in organ fibrosis – resolution and assessment20
Point-by-Point Progress: Gonorrhea Point of Care Tests20
Alpha-gal syndrome: challenges to understanding sensitization and clinical reactions to alpha-gal20
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma19
Concentration of cell-free DNA in different tumor types19
Nanomaterial-based Optical and Electrochemical Biosensors for Amyloid beta and Tau: Potential for early diagnosis of Alzheimer’s Disease18
Aptamer-based sensing of breast cancer biomarkers: a comprehensive review of analytical figures of merit18
Common mutations of interest in the diagnosis of amyotrophic lateral sclerosis: how common are common mutations in ALS genes?18
Saliva as a sample type for SARS-CoV-2 detection: implementation successes and opportunities around the globe18
Metabolomics-based predictive biomarkers of radiation injury and countermeasure efficacy: current status and future perspectives18
Blood-based traumatic brain injury biomarkers – Clinical utilities and regulatory pathways in the United States, Europe and Canada18
Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer18
Circulating tumor cell clusters: Insights into tumour dissemination and metastasis17
Antimicrobial resistance prediction in Neisseria gonorrhoeae: current status and future prospects17
Challenges in the clinical implementation of precision medicine companion diagnostics17
Diagnostic and Prognostic Significance of Dysregulated Expression of Circular RNAs in Osteosarcoma17
A review on human body fluids for the diagnosis of viral infections: scope for rapid detection of COVID-1917
An overview of using fungal DNA for the diagnosis of invasive mycoses17
Performance comparison of the Cobas® Liat® and Cepheid® GeneXpert® systems on SARS-CoV-2 detection in nasopharyngeal swab and posterior oropharyngeal saliva16
Point-of-care diagnostics for invasive aspergillosis: nearing the finish line16
Predictive biomarkers for systemic therapy of hepatocellular carcinoma16
RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?16
Emerging Role of Extracellular Vesicles in Biomarking the Gastrointestinal Diseases16
Circular RNAs: novel diagnostic and therapeutic targets for ischemic stroke16
Advances in gold nanoparticle technology as a tool for diagnostics and treatment of cancer16
Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals15
Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes15
dPCR application in liquid biopsies: divide and conquer14
Mid-regional pro-adrenomedullin as a supplementary tool to clinical parameters in cases of suspicion of infection in the emergency department14
Recent advances in the diagnosis of COVID-19: a bird’s eye view14
Evolution of approaches to identify melanoma missing heritability14
Recent advances in the diagnosis monkeypox: implications for public health14
New and developing diagnostic platforms for COVID-19: A systematic review14
Clinical genomics and contextualizing genome variation in the diagnostic laboratory13
Potential of CRISPR/Cas system in the diagnosis of COVID-19 infection13
Impact of non-antibiotic drugs on the human intestinal microbiome13
The importance of genomic analysis in cracking the coronavirus pandemic13
Advances in quantitative immunohistochemistry and their contribution to breast cancer13
Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved : a systematic review13
Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling13
Cervical cancer risk profiling: molecular biomarkers predicting the outcome of hrHPV infection13
Human tear fluid analysis for clinical applications: progress and prospects13
Improving laboratory diagnostics in myasthenia gravis13
Clinical relevance ofliquid biopsyin breast cancer: update in 202012
Tumor treating fields: a comprehensive overview of the underlying molecular mechanism12
Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors – A systematic review12
Applications of the CRISPR-Cas system for infectious disease diagnostics12
Optimizing testing regimes for the detection of COVID-19 in children and older adults12
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer12
Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer12
Point-of-care COVID-19 testing in the emergency department: current status and future prospects11
Update on urine as a biomarker in cancer: a necessary review of an old story11
A profile of the binx health io® molecular point-of-care test for chlamydia and gonorrhea in women and men11
An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer11
Improving genetic diagnostics of skeletal muscle channelopathies11
The diagnostic accuracy of seven commercial molecular in vitro SARS-CoV-2 detection tests: a rapid meta-analysis11
MicroRNA-217: a therapeutic and diagnostic tumor marker11
Spatial profiling technologies and applications for brain cancers11
Noninvasive prenatal screening for fetal sex chromosome aneuploidies11
Quantifying SARS-CoV-2 viral load: current status and future prospects11
Identification of the candidate lncRNA biomarkers for acute kidney injury: a systematic review and meta-analysis11
microRNAs as novel diagnostic biomarkers in endometriosis patients: a systematic review and meta-analysis11
Quantitative versus qualitative estrogen and luteinizing hormone testing for personal fertility monitoring11
Liquid biopsy markers for stroke diagnosis10
Salivary biomarkers associated with obstructive sleep apnea: a systematic review10
Future potential of metagenomics in microbiology laboratories10
Viral metagenomic sequencing in the diagnosis of meningoencephalitis: a review of technical advances and diagnostic yield10
Application of selected biosensor techniques in clinical diagnostics10
Oral Potentially Malignant Disorders (OPMD): What is the clinical utility of dysplasia grade?10
Assessing our approach to diagnosing Fibromyalgia10
Rapid metagenomics for diagnosis of bloodstream and respiratory tract nosocomial infections: current status and future prospects10
Advances in RT-LAMP for COVID-19 testing and diagnosis10
Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis10
True or false: what are the factors that influence COVID-19 diagnosis by RT-qPCR?10
Construction of a 5-methylcytosine-Related Molecular Signature to Inform the Prognosis and Immunotherapy of Lung Squamous Cell Carcinoma10
Common markers of testicular Sertoli cells10
Role of artificial intelligence and vibrational spectroscopy in cancer diagnostics10
Diagnostic accuracy of cerebrospinal fluid and serum-isolated extracellular vesicles for glioblastoma: a systematic review and meta-analysis9
Loop-mediated isothermal amplification methods for diagnosis of visceral leishmaniasis (kala-azar) – a systematic review9
Highly sensitive droplet digital PCR-based diagnostics for the surveillance of malaria vector populations in low transmission and incipient resistance settings9
The relationship between positivity for COVID-19 RT-PCR and symptoms, clinical findings, and mortality in Turkey9
At-home coronavirus testing: the next game-changer?9
ASSURED-SQVM diagnostics for COVID-19: addressing the why, when, where, who, what and how of testing9
Advances in the clinical use of collagen as biomarker of liver fibrosis9
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach9
Current and future strategies for diagnostic and management of obstructive sleep apnea9
Cell-free DNA as a potential biomarker for preeclampsia8
Blood concentrations of proapoptotic sFas and antiapoptotic Bcl2 and COVID-19 patient mortality8
Molecular imaging in immuno-oncology: current status and translational perspectives8
Utility of droplet digital PCR and NGS-based CNV clinical assays in hearing loss diagnostics: current status and future prospects8
Update on molecular companion diagnostics - a future in personalized medicine beyond Sanger sequencing8
Beyond the Usual Suspects: Expanding on Mutations and Detection for Familial Hypercholesterolemia8
Investigation of LOY in Prostate, Pancreatic, and Colorectal Cancers in males: A case–control study8
Companion and complementary diagnostics: an important treatment decision tool in precision medicine8
The potential of circulating exosomal RNA biomarkers in cancer8
A computational prognostic model of lncRNA signature for clear cell renal cell carcinoma with genome instability7
The detrimental impact of elevated Ferritin to Iron ratio on in-hospital prognosis of patients with COVID-197
Screening for ROS1 fusions in patients with advanced non-small cell lung carcinomas using the VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody7
The potential diagnostic value of extracellular vesicle miRNA for human non-small cell lung cancer: a systematic review and meta-analysis7
Polygenic and Network-based studies in risk identification and demystification of cancer7
Comparative evaluation of a dual-target real-time RT-PCR assay for COVID-19 diagnosis and assessment of performance in pooled saliva and nasopharyngeal swab samples7
Circulating tumor cells as prognostic biomarkers in breast cancer: current status and future prospects7
Insight into diagnosis of female genital tuberculosis7
Bladder neoplasms and NF-κB: an unfathomed association7
Alpha-defensin does not provide additional benefit over leukocyte esterase in the diagnosis of periprosthetic joint infection7
Brain exosomes as minuscule information hub for Autism Spectrum Disorder7
Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer: an update7
Gene fusions in vascular tumors and their underlying molecular mechanisms7
The prenatal exome – a door to prenatal diagnostics?7
Review of current status of molecular diagnosis and characterization of monogenic diabetes mellitus: a focus on next-generation sequencing7
Using lipocalin as a prognostic biomarker in acute kidney injury7
Molecular analysis of the destruction of articular joint tissues by Raman spectroscopy7
Unveiling the underpinnings of various non-conventional ELISA variants: a review article7
Food allergy severity predictions based on cellular in vitro tests7
Neuroimaging with PET/CT in chronic traumatic encephalopathy: what nuclear medicine can do to move the field forward7
Advances in the diagnosis of autoimmune diseases based on citrullinated peptides/proteins7
A profile of the FDA-approved and CE/IVD-marked AptimaMycoplasma genitaliumassay (Hologic) and key priorities in the management ofM. genitaliuminfections7
Predicting wet age-related macular degeneration (AMD) using DARC (detecting apoptosing retinal cells) AI (artificial intelligence) technology6
Nonalcoholic fatty liver disease: use of diagnostic biomarkers and modalities in clinical practice6
Toward an individualized determination of dialysis adequacy: a narrative review with special emphasis on incremental hemodialysis6
Protein array-based companion diagnostics in precision medicine6
Gastrin-releasing peptide receptor agonists and antagonists for molecular imaging of breast and prostate cancer: from pre-clinical studies to translational perspectives6
The value of biomarker-guided antibiotic therapy6
Emerging biomarkers in chronic lung allograft dysfunction6
The clinical application of metagenomic next-generation sequencing for detecting pathogens in bronchoalveolar lavage fluid: case reports and literature review6
Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rh6
Evaluation of the performance of the BD MAX MDR-TB test in the diagnosis of Mycobacterium tuberculosis complex in extrapulmonary and pulmonary samples6
Next-generation sequencing for the diagnosis of hepatitis B: current status and future prospects6
Recent advances in rapid antimicrobial susceptibility testing systems6
Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations6
Application of perovskites in bioimaging: the state-of-the-art and future developments6
Nuclease activity: an exploitable biomarker in bacterial infections6
Diagnostic techniques in HPV infections and the need to implement them in plantar lesions: A systematic review6
Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma6
Infrared analyzers for the measurement of breastmilk macronutrient content in the clinical setting6
Evaluation of the Onclarity HPV assay on the high-throughput COR system6
Point of care molecular and antigen detection tests for COVID-19: current status and future prospects5
Molecular techniques for the genomic viral RNA detection of West Nile, Dengue, Zika and Chikungunya arboviruses: a narrative review5
Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease5
Heart failure risk estimation based on novel biomarkers5
The current and future applications of in situ hybridization technologies in anatomical pathology5
Clinicopathologic and prognostic roles of circular RNA plasmacytoma variant translocation 1 in various cancers5
An evaluation of liposome-based diagnostics of pulmonary and extrapulmonary tuberculosis5
Advances in tissue-based imaging: impact on oncology research and clinical practice5
Loop-mediated isothermal amplification for Candida species surveillance in under-resourced setting: a review of evidence5
Diagnostic value of monocyte to high-density lipoprotein ratio in acute aortic dissection in a Chinese han population5
Is there a role for microRNAs in epilepsy diagnostics?5
An updated review of the role of lncRNAs and their contribution in various molecular subtypes of breast cancer5
Retrospective analysis of the risk factors associated with failure in obtaining effective noninvasive prenatal test results and pregnancy outcomes: a case-control study5
Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis5
Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma5
Genomic characterization reveals potential biomarkers in nasopharyngeal carcinoma patients with relapse5
Detection of SARS-CoV-2 in tissue: the comparative roles of RT-qPCR, in situ RNA hybridization, and immunohistochemistry5
Monitoring immunomodulation in patients with sepsis5
Updates in diagnosing polycystic ovary syndrome-related infertility5
Molecular sequencing technologies in the diagnosis and management of prosthetic joint infections5
Dual agonist–antagonist effect of ulipristal acetate in human endometrium and myometrium5
Neuroimaging in hereditary spastic paraplegias: from qualitative cues to precision biomarkers4
α-synuclein as an emerging pathophysiological biomarker of Alzheimer’s disease4
Diagnostic value of circulating lncRNAs as biomarkers of digestive system cancers: A systematic review and meta-analysis4
Monitoring hepatitis B by using point-of-care testing: biomarkers, current technologies, and perspectives4
Genetic variations as molecular diagnostic factors for idiopathic male infertility: current knowledge and future perspectives4
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies4
Saliva diagnostics: emerging techniques and biomarkers for salivaomics in cancer detection4
Fetal screening and whole genome sequencing: where are the limits?4
An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA4
Future potential of Rapid Acceleration of Diagnostics (RADx Tech) in molecular diagnostics4
Analytical and clinical validation of an RNA sequencing-based assay for quantitative, accurate evaluation of a molecular signature response classifier in rheumatoid arthritis4
Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma4
An update on companion and complementary diagnostic assays for PD-1/PD-L1 checkpoint inhibitors in NSCLC4
Advancing cervical cancer diagnosis and screening with spectroscopy and machine learning4
Prognostic value of baculoviral IAP repeat containing 5 expression as a new biomarker in lung adenocarcinoma: a meta-analysis4
Values of liquid biopsy in early detection of cancer: results from meta-analysis4
Diagnostic utility of rapid sequencing in critically ill infants: a systematic review and meta-analysis4
Virtual tissue staining in pathology using machine learning4
Genetic testing for the clinician in prostate cancer4
Impact of the new European Union In Vitro Diagnostics Regulation on the practice of hospital diagnostic laboratories4
Research tests for the diagnosis of tuberculosis infection4
Advances in tuberculous meningitis diagnosis4
Diagnostic and prognostic value of long noncoding RNAs in sepsis: a systematic review and meta-analysis3
Impact of the COVID-19 pandemic on Molecular Diagnostics3
Enumeration and molecular characterization of circulating tumor cells as an innovative tool for companion diagnostics in breast cancer3
Noncoding RNAs as a potential biomarker for the prognosis of bladder cancer: a systematic review and meta-analysis3
How to effectively utilize imaging in disease-modifying treatments for osteoarthritis clinical trials: the radiologist’s perspective3
Comparative performance of two commercial sample-to-result systems for hepatitis C virus quantitation and genotyping3
Diagnostic accuracy of CRISPR technology for detecting SARS-CoV-2: a systematic review and meta-analysis3
The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression3
Epigenetic signatures in gastric cancer: current knowledge and future perspectives3
A profile of the GenePOC Carba C assay for the detection and differentiation of gene sequences associated with carbapenem-non-susceptibility3
The value of companion diagnostics in oncology drug development3
The clinical importance of high-sensitivity cardiac troponin measurements for risk prediction in non-cardiac surgery3
Molecular determination of insect venom allergies3
The MALAT1-breast cancer interplay: insights and implications3
The impact of the COVID-19 pandemic on addressing common barriers to pharmacy-based point-of-care testing3
Diagnostic significance of heart-type fatty acid-binding protein as a potential biomarker to predict the mortality rate of patients with sepsis: a systematic review and meta-analysis3
Mutations of key driver genes in gastric cancer metastasis risk: a systematic review and meta-analysis3
An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections3
Noninvasive imaging assessment of portal hypertension: where are we now and where does the future lie?3
Diagnostic profile of the AmplideX Fragile X Dx and Carrier Screen Kit for diagnosis and screening of fragile X syndrome and other FMR1-related disorders3
Relationship between diagnostic accuracy of microRNAs for NSCLC and number of combined microRNAs: an overview with meta-analysis3
Known biomarkers for monitoring pregnancy complications3
A stroll through the present and future of testicular germ cell tumour biomarkers3
The biomolecular corona of extracellular nanoparticles holds new promises for advancing clinical molecular diagnostics3
Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers3
SSR4 as a prognostic biomarker and related with immune infiltration cells in colon adenocarcinoma3
Villin expression in human tumors: a tissue microarray study on 14,398 tumors3
Clinical utility of the 'Determine HBsAg' Point-of-Care Test for Diagnosis of Hepatitis B Surface Antigen in Africa3
0.030189990997314